Brian Stephenson

Former Chief Financial Officer and Secretary (our “Former CFO”)

CFO CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Former Chief Financial Officer	$156,431	—	—	—	—	$528,230	$684,661
2024	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Former Chief Financial Officer	$661,046	$328,000	$4,318,393	$342,088	—	$14,160	$5,663,687
2023	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Former Chief Financial Officer	$650,000	$487,500	$3,170,759	$2,329,997	—	$13,740	$6,651,996
2022	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Former Chief Financial Officer	$650,000	$487,500	$1,807,692	—	—	$12,200	$2,957,392
2021	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Chief Financial Officer	$600,000	$225,000	$1,442,224	$6,398,473	—	$11,600	$8,677,297
2020	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Chief Financial Officer	$550,000	$712,500	$789,494	$2,099,996	—	$11,943	$4,163,933
2019	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Chief Financial Officer	$420,000	$189,000	$132,600	$3,430,781	—	$26,586	$4,198,967
2018	BridgeBio Pharma, Inc. (BBIO)	Ph.D., CFA Chief Financial Officer	$74,375	$330,240	$1,942,500	—	—	—	$2,347,115

Executive changes

Appointed Chief Financial Officer at Faeth Therapeutics, Inc. (FTH)
2026-06-13
Terminated Chief Financial Officer at BridgeBio Pharma, Inc. (BBIO)
2025-03-17

Earnings-call appearances

No earnings-call appearances recorded yet.